Authors:
JACKSON SR
TWEEDDALE MG
BARNETT MJ
SPINELLI JJ
SUTHERLAND HJ
REECE DE
KLINGEMANN HG
NANTEL SH
FUNG HC
TOZE CL
PHILLIPS GL
SHEPHERD JD
Citation: Sr. Jackson et al., ADMISSION OF BONE-MARROW TRANSPLANT RECIPIENTS TO THE INTENSIVE-CARE UNIT - OUTCOME, SURVIVAL AND PROGNOSTIC FACTORS, Bone marrow transplantation, 21(7), 1998, pp. 697-704
Authors:
KOC ON
GERSON SL
PHILLIPS GL
COOPER BW
KUTTEH L
VANZANT G
REECE DE
FOX RM
SCHUPP JE
TAINER N
LAZARUS HM
Citation: On. Koc et al., AUTOLOGOUS CD34(- EFFECTS OF OVERNIGHT STORAGE ON PERIPHERAL-BLOOD PROGENITOR-CELL ENRICHMENT AND ENGRAFTMENT() CELL TRANSPLANTATION FOR PATIENTS WITH ADVANCED LYMPHOMA ), Bone marrow transplantation, 21(4), 1998, pp. 337-343
Citation: Gl. Phillips et al., THE USE OF CONVENTIONAL SALVAGE CHEMOTHERAPY BEFORE DOSE-INTENSIVE CYTOTOXIC THERAPY AND AUTOLOGOUS TRANSPLANTATION FOR AGGRESSIVE-HISTOLOGY LYMPHOMA - A CASE FOR REEVALUATION, Leukemia & lymphoma, 26(5-6), 1997, pp. 507-513
Authors:
DALAL BI
WU V
BARNETT MJ
HORSMAN DE
SPINELLI JJ
NAIMAN SC
SHEPHERD JD
NANTEL SH
REECE DE
SUTHERLAND HJ
KLINGEMANN HG
PHILLIPS GL
Citation: Bi. Dalal et al., INDUCTION FAILURE IN DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IS ASSOCIATEDWITH EXPRESSION OF HIGH-LEVELS OF CD34 ANTIGEN BY THE LEUKEMIC BLASTS, Leukemia & lymphoma, 26(3-4), 1997, pp. 299-306
Citation: De. Reece et Gl. Phillips, INTENSIVE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR HODGKINS-DISEASE IN FIRST RELAPSE AFTER COMBINATION CHEMOTHERAPY, Leukemia & lymphoma, 21(3-4), 1996, pp. 245-253
Authors:
MICALLEF INM
BARNETT MJ
DAVIS JH
SCHULTZ KR
KLINGEMANN HG
SHEPHERD JD
SUTHERLAND HJ
TOZE CL
HOGGE DE
PRITCHARD SL
MUNN KJ
BROCKINGTON DA
FUNG HC
ROGERS PCJ
CHAN KW
REECE DE
PHILLIPS GL
NANTEL SH
Citation: Inm. Micallef et al., A REVIEW OF THE VANCOUVER EXPERIENCE WITH BONE-MARROW TRANSPLANTATION(BMT) USING VOLUNTEER UNRELATED DONORS (VUD), Blood, 88(10), 1996, pp. 1046-1046
Authors:
TOZE CL
REECE DE
WAKEFIELD LK
LE A
MACDOUGALL CA
SHEPHERD JD
NANTEL SH
SUTHERLAND HJ
KLINGEMANN HG
HOGGE DE
BARNETT MJ
Citation: Cl. Toze et al., OUTPATIENT ANTIBIOTIC-THERAPY FOR LEUKEMIA BONE-MARROW TRANSPLANT DAY-CARE PATIENTS - PROGRAM CHARACTERIZATION AND EVALUATION, Blood, 88(10), 1996, pp. 1197-1197
Authors:
TEZCAN H
BARNETT MJ
BREDESON CN
REECE DE
SHEPHERD JD
DALAL BI
HORSMAN DE
KLINGEMANN HG
NANTEL SH
SPINELLI JJ
SUTHERLAND HJ
PHILLIPS GL
Citation: H. Tezcan et al., TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN PATIENTS PRESENTING AT VANCOUVER-GENERAL-HOSPITAL FROM 1983 TO 1992, Leukemia & lymphoma, 16(5-6), 1995, pp. 439-444
Authors:
KLINGEMANN HG
EAVES CJ
BARNETT MJ
EAVES AV
HOGGE DE
LANDSDORP P
NANTEL SH
REECE DE
SHEPHERD JD
SUTHERLAND HJ
PHILLIPS GL
Citation: Hg. Klingemann et al., AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA INFIRST REMISSION WITH IL-2-CULTURED MARROW OR PERIPHERAL-BLOOD STEM-CELLS FOLLOWED BY IN-VIVO IL-2, Onkologie, 18(1), 1995, pp. 44-47
Authors:
PHILLIPS GL
NEVILL TJ
SPINELLI JJ
NANTEL SH
KLINGEMANN HG
BARNETT MJ
SHEPHERD JD
CHAN KW
MEHARCHAND JM
SUTHERLAND HJ
REECE DE
MESSNER HA
Citation: Gl. Phillips et al., PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING UNRELATED DONOR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(2), 1995, pp. 213-219
Authors:
REECE DE
SHEPHERD JD
KLINGEMANN HG
SUTHERLAND HJ
NANTEL SH
BARNETT MJ
SPINELLI JJ
PHILLIPS GL
Citation: De. Reece et al., TREATMENT OF MYELOMA USING INTENSIVE THERAPY AND ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(1), 1995, pp. 117-123
Citation: Rjg. Cuthbert et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA - THE VANCOUVER EXPERIENCE, Clinical and investigative medicine, 18(2), 1995, pp. 122-130
Authors:
REECE DE
BARNETT MJ
SHEPHERD JD
HOGGE DE
KLASA RJ
NANTEL SH
SUTHERLAND HJ
KLINGEMANN HG
FAIREY RN
VOSS NJ
CONNORS JM
OREILLY SE
SPINELLI JJ
PHILLIPS GL
Citation: De. Reece et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATIN (CBV+ -P) AND AUTOLOGOUS TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE WHO FAIL TO ENTER A COMPLETE REMISSION AFTER COMBINATION CHEMOTHERAPY/, Blood, 86(2), 1995, pp. 451-456
Authors:
FUNG HC
VOSS NJ
BARNETT MJ
FAIREY RN
REECE DE
PHILLIPS GL
SHEPHERD JD
NANTEL SH
SUTHERLAND HJ
TOZE CL
KLINGEMANN HG
Citation: Hc. Fung et al., LOW-DOSE THORACOABDOMINAL IRRADIATION FOR TREATMENT OF ADVANCED CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(10), 1995, pp. 1550-1550
Authors:
SHEPHERD JD
BARNETT MJ
BROCKINGTON DA
FUNG HC
KLINGEMANN HG
NANTEL SH
REECE DE
SUTHERLAND HJ
THIERMAN JG
TOZE CL
PHILLIPS GL
Citation: Jd. Shepherd et al., INDUCTION AND CONSOLIDATION THERAPY WITH INTERMEDIATE-DOSE CYTARABINE, MITOXANTRONE AND ETOPOSIDE IN PATIENTS GREATER-THAN-OR-EQUAL-TO-60 YEARS WITH ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 2075-2075
Authors:
RAYANI SA
NIMMO CJR
FRIGHETTO L
MARTINUSEN SM
NICKOLOFF DM
REECE DE
JEWESSON PJ
Citation: Sa. Rayani et al., IMPLEMENTATION AND EVALUATION OF A STANDARDIZED HERPES-SIMPLEX VIRUS PROPHYLAXIS PROTOCOL ON A LEUKEMIA BONE-MARROW TRANSPLANT UNIT, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 852-856
Citation: Jb. Epstein et De. Reece, TOPICAL CYCLOSPORINE-A FOR TREATMENT OF ORAL CHRONIC GRAFT-VERSUS-HOST DISEASE, Bone marrow transplantation, 13(1), 1994, pp. 81-86
Authors:
BARNETT MJ
EAVES CJ
PHILLIPS GL
GASCOYNE RD
HOGGE DE
HORSMAN DE
HUMPHRIES RK
KLINGEMANN HG
LANSDORP PM
NANTEL SH
REECE DE
SHEPHERD JD
SPINELLI JJ
SUTHERLAND HJ
EAVES AC
Citation: Mj. Barnett et al., AUTOGRAFTING WITH CULTURED MARROW IN CHRONIC MYELOID-LEUKEMIA - RESULTS OF A PILOT-STUDY, Blood, 84(3), 1994, pp. 724-732
Authors:
TOZE CL
BARNETT MJ
KLINGEMANN HG
NANTEL SH
REECE DE
SHEPHERD JD
SUTHERLAND HJ
PHILLIPS GL
Citation: Cl. Toze et al., PREVENTATIVE STRATEGIES FOR CYTOMEGALOVIRUS (CMV) INTERSTITIAL PNEUMONITIS (IP) POST ALLOGENEIC BONE-MARROW TRANSPLANT (ALLO-BMT) - A DECISION AND COST-ANALYSIS, Blood, 84(10), 1994, pp. 10000088-10000088
Authors:
JACKSON SR
SHEPHERD JD
TWEEDDALE MG
BARNETT MJ
SPINELLI JJ
SUTHERLAND HJ
REECE DE
KLINGEMANN HG
NANTEL SH
PHILLIPS GL
Citation: Sr. Jackson et al., ADMISSION OF BONE-MARROW TRANSPLANT (BMT) RECIPIENTS TO THE INTENSIVE-CARE UNIT (ICU), Blood, 84(10), 1994, pp. 10000485-10000485